Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients

The goal of therapy in chronic hepatitis C virus(HCV) infection is sustained virological response(SVR) which reflects HCV eradication. Treatment against HCV has dramatically improved with the recent availability of direct-acting antivirals(DAAs) including sofosbuvir, simeprevir, daclatasvir, ledipas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2015-08, Vol.21 (32), p.9526-9533
Hauptverfasser:	Cholongitas, Evangelos, Pipili, Chrysoula, Papatheodoridis, George
Format:	Artikel
Sprache:	eng
Schlagworte:	acting agents Liver antiviral Antiviral Agents - adverse effects Antiviral Agents - therapeutic use C Direct Drug Interactions Drug Therapy, Combination End Stage Liver Disease - diagnosis End Stage Liver Disease - surgery End Stage Liver Disease - virology Hepatitis Hepatitis C, Chronic - complications Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - drug therapy Humans Liver Cirrhosis - diagnosis Liver Cirrhosis - surgery Liver Cirrhosis - virology Liver Transplantation - adverse effects Minireviews Patient Selection Recurrence Risk Assessment Risk Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!